Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Canada
  4. Toronto Stock Exchange
  5. MediPharm Labs Corp.
  6. News
  7. Summary
    LABS   CA58504D1006

MEDIPHARM LABS CORP.

(LABS)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Medipharm Labs Corp. Appoints Chris Taves as Chairman of the Board

08/16/2021 | 07:15am EDT

MediPharm Labs Corp. announced that it has unanimously appointed Chris Taves as Chairman of the Board effective immediately. Mr. Taves joined MediPharm’s Board in July 2020 and also chairs its Audit Committee. As Chairman, Chris Taves will oversee the leadership of the Company into its next stage of growth as a leader in the supply of cannabis-based drugs and API to pharmaceutical companies around the world.


© S&P Capital IQ 2021
All news about MEDIPHARM LABS CORP.
10/21MEDIPHARM LABS : Appoints New Chief Executive Officer
AQ
10/21MediPharm Labs Corp. Appoints Bryan Howcroft as Chief Executive Officer, Effective Nove..
CI
10/21MediPharm Labs Corp. Appoints Bryan Howcroft as Director, Effective November 15, 2021
CI
10/19MEDIPHARM LABS : Completes New Cannabis Oil Shipment to German Partner
MT
10/19MEDIPHARM LABS : Completes a New Cannabis Oil Delivery to German Partner Vayamed
GL
10/19MediPharm Labs Completes New Cannabis Oil Delivery to German Partner Vayamed
CI
08/31MEDIPHARM LABS : Health Canada Approves Start of Phase 2 Trial Using MediPharm Labs CBD Pr..
MT
08/31Insomnia Treatment Study using MediPharm Labs CBD50 Product to Proceed to Phase 2 with ..
GL
08/19MEDIPHARM LABS : Australia Receives Government Grant to Assist with International Expansio..
AQ
08/18MEDIPHARM LABS BRIEF : Receives Export Authorization to Ship Medical Cannabis to Brazil
MT
More news
Financials
Sales 2021 26,2 M 21,1 M 21,1 M
Net income 2021 -33,8 M -27,3 M -27,3 M
Net Debt 2021 - - -
P/E ratio 2021 -1,85x
Yield 2021 -
Capitalization 70,0 M 56,6 M 56,5 M
Capi. / Sales 2021 2,68x
Capi. / Sales 2022 1,19x
Nbr of Employees 204
Free-Float 93,2%
Chart MEDIPHARM LABS CORP.
Duration : Period :
MediPharm Labs Corp. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MEDIPHARM LABS CORP.
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 4
Last Close Price 0,27 CAD
Average target price 0,65 CAD
Spread / Average Target 145%
EPS Revisions
Managers and Directors
Keith Strachan Chief Executive Officer, President & Director
Greg Hunter Chief Financial Officer
Chris Taves Chairman
Ina Shira Dubinsky Lead Scientist-Secondary Processing
William Gordon Director-Information Technology
Sector and Competitors
1st jan.Capi. (M$)
MEDIPHARM LABS CORP.-49.06%58
CURALEAF HOLDINGS, INC.-16.60%7 268
BEIJING TONGRENTANG CO., LTD37.36%7 038
CANOPY GROWTH CORPORATION-46.30%5 349
DONG-E-E-JIAO CO.,LTD.6.04%4 286
CRONOS GROUP INC.-22.06%2 079